{"id":400384,"date":"2020-12-15T16:08:18","date_gmt":"2020-12-15T21:08:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400384"},"modified":"2020-12-15T16:08:18","modified_gmt":"2020-12-15T21:08:18","slug":"nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/","title":{"rendered":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">REDWOOD CITY, Calif.<\/span>, <span class=\"xn-chron\">Dec. 15, 2020<\/span> \/PRNewswire\/ &#8212; Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. <span class=\"xn-person\">Keith Grossman<\/span>, Nevro&#8217;s Chairman, CEO and President, will present at the 39<sup>th<\/sup> Annual J.P. Morgan Healthcare Conference on <span class=\"xn-chron\">Tuesday, January 12, 2021<\/span>, at <span class=\"xn-chron\">4:30 pm Eastern Time<\/span> \/ <span class=\"xn-chron\">1:30 pm Pacific Time<\/span>.<\/p>\n<p>A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro&#8217;s website at\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=3596121199&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2879534-1%26h%3D4227538825%26u%3Dhttp%253A%252F%252Fwww.nevro.com%252F%26a%3Dwww.nevro.com&amp;a=www.nevro.com\" rel=\"nofollow noopener noreferrer\">www.nevro.com<\/a>.\u00a0 <\/p>\n<p>\n        <b>Internet Posting of Information<\/b>\n      <\/p>\n<p>Nevro routinely posts information that may be important to investors in the &#8220;Investor Relations&#8221; section of its website at <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=3208944026&amp;u=http%3A%2F%2Fwww.nevro.com%2F&amp;a=www.nevro.com\" rel=\"nofollow noopener noreferrer\">www.nevro.com<\/a>.\u00a0 The company encourages investors and potential investors to consult the Nevro website regularly for important information about Nevro.<\/p>\n<p>\n        <b>About Nevro<\/b>\n      <\/p>\n<p>Headquartered in <span class=\"xn-location\">Redwood City, California<\/span>, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based, non-pharmacologic neuromodulation platform for the treatment of chronic pain. HF10 therapy has demonstrated the ability to reduce or eliminate opioids in \u226565% of patients across six peer-reviewed clinical studies. The Senza<sup>\u00ae<\/sup>\u00a0System, Senza II\u2122 System, and the Senza<sup>\u00ae<\/sup>\u00a0Omnia\u2122 System\u00a0are the only SCS systems that deliver Nevro&#8217;s proprietary HF10<sup>\u00ae<\/sup>\u00a0therapy. Senza, Senza II, Senza Omnia, HF10, Nevro and the Nevro logo are trademarks of Nevro Corp.<\/p>\n<p>To learn more about Nevro, connect with us on\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=2892349796&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2957666-1%26h%3D3237026080%26u%3Dhttps%253A%252F%252Fwww.linkedin.com%252Fcompany%252Fnevro%252F%26a%3DLinkedIn&amp;a=LinkedIn\" rel=\"nofollow noopener noreferrer\">LinkedIn<\/a>,\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=3888502303&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2957666-1%26h%3D3756300817%26u%3Dhttps%253A%252F%252Ftwitter.com%252Fnevro_hf10%26a%3DTwitter&amp;a=Twitter\" rel=\"nofollow noopener noreferrer\">Twitter<\/a>,\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=3591852212&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2957666-1%26h%3D233801870%26u%3Dhttps%253A%252F%252Fwww.facebook.com%252FHF10therapy%252F%26a%3DFacebook&amp;a=Facebook\" rel=\"nofollow noopener noreferrer\">Facebook<\/a>\u00a0and\u00a0<a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3012877-1&amp;h=3644494953&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2957666-1%26h%3D464884540%26u%3Dhttps%253A%252F%252Fwww.instagram.com%252Fnevro_hf10%252F%26a%3DInstagram&amp;a=Instagram\" rel=\"nofollow noopener noreferrer\">Instagram<\/a>.<\/p>\n<p>\n        <b><br \/>\n          <span>Investors and Media:<\/span><br \/>\n        <\/b><br \/>\n        <br \/>\n        <span><br \/>\n          <span class=\"xn-person\">Julie Dewey<\/span>, IRC<\/span><br \/>\n        <br \/>\n        <span>Nevro Corp.<\/span><br \/>\n        <br \/>\n        <span>Vice President, Investor Relations &amp; Corp Communications<\/span><br \/>\n        <br \/>\n        <span>650-433-3247\u00a0 |\u00a0 <\/span><br \/>\n        <span><br \/>\n          <a target=\"_blank\" href=\"mailto:julie.dewey@nevro.com\" rel=\"nofollow noopener noreferrer\">julie.dewey@nevro.com<\/a><br \/>\n        <\/span>\n      <\/p>\n<p>\n        <span><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder5364\">\n<p>\n              <a href=\"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.html\" target=\"_blank\" rel=\"nofollow noopener noreferrer\"><br \/>\n                <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg\" title=\".\" alt=\".\" \/><br \/>\n              <\/a>\n            <\/p>\n<\/p><\/div>\n<p>        <\/span>\n      <\/p>\n<p>\n        <span \/>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=SF23884&amp;sd=2020-12-15\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"http:\/\/www.prnewswire.com\/news-releases\/nevro-to-present-at-39th-annual-jp-morgan-healthcare-conference-on-tuesday-january-12-2021-301193447.html\">http:\/\/www.prnewswire.com\/news-releases\/nevro-to-present-at-39th-annual-jp-morgan-healthcare-conference-on-tuesday-january-12-2021-301193447.html<\/a><\/p>\n<p>SOURCE  Nevro Corp.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=SF23884&amp;Transmission_Id=202012151605PR_NEWS_USPR_____SF23884&amp;DateId=20201215\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire REDWOOD CITY, Calif., Dec. 15, 2020 \/PRNewswire\/ &#8212; Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro&#8217;s Chairman, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 4:30 pm Eastern Time \/ 1:30 pm Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro&#8217;s website at\u00a0www.nevro.com.\u00a0 Internet Posting of Information Nevro routinely posts information that may be important to investors in the &#8220;Investor Relations&#8221; section of its website at www.nevro.com.\u00a0 The company encourages investors and potential investors to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-400384","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire REDWOOD CITY, Calif., Dec. 15, 2020 \/PRNewswire\/ &#8212; Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro&#8217;s Chairman, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 4:30 pm Eastern Time \/ 1:30 pm Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro&#8217;s website at\u00a0www.nevro.com.\u00a0 Internet Posting of Information Nevro routinely posts information that may be important to investors in the &#8220;Investor Relations&#8221; section of its website at www.nevro.com.\u00a0 The company encourages investors and potential investors to &hellip; Continue reading &quot;Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-15T21:08:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021\",\"datePublished\":\"2020-12-15T21:08:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/\"},\"wordCount\":311,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/\",\"name\":\"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"datePublished\":\"2020-12-15T21:08:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/466682\\\/Nevro_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/","og_locale":"en_US","og_type":"article","og_title":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk","og_description":"PR Newswire REDWOOD CITY, Calif., Dec. 15, 2020 \/PRNewswire\/ &#8212; Nevro Corp.\u00a0(NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced\u00a0that D. Keith Grossman, Nevro&#8217;s Chairman, CEO and President, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 4:30 pm Eastern Time \/ 1:30 pm Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro&#8217;s website at\u00a0www.nevro.com.\u00a0 Internet Posting of Information Nevro routinely posts information that may be important to investors in the &#8220;Investor Relations&#8221; section of its website at www.nevro.com.\u00a0 The company encourages investors and potential investors to &hellip; Continue reading \"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-15T21:08:18+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021","datePublished":"2020-12-15T21:08:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/"},"wordCount":311,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/","name":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","datePublished":"2020-12-15T21:08:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/466682\/Nevro_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/nevro-to-present-at-39th-annual-j-p-morgan-healthcare-conference-on-tuesday-january-12-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=400384"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400384\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=400384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=400384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=400384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}